Cargando…
Perspectives to mitigate payer uncertainty in health technology assessment of novel oncology drugs
Reimbursement decisions on new oncology drugs are now often made while uncertainty remains about a drug's risk–benefit profile. One consequence of this is a delay in patient access to valuable new medicines. We share our perspectives on strategies to mitigate sources of uncertainty in the healt...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Routledge
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346722/ https://www.ncbi.nlm.nih.gov/pubmed/30719243 http://dx.doi.org/10.1080/20016689.2018.1562861 |